US EditionAntimicrobial resistance in Neisseria gonorrhoeae and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational study - AMR Insights
Summary by AMR Insights
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Antimicrobial resistance in Neisseria gonorrhoeae and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational study - AMR Insights
The European Centre for Disease Prevention and Control (ECDC) has been monitoring antimicrobial resistance (AMR) in Neisseria gonorrhoeae since 2009. This study aimed to compare Euro-GASP 2022 data with the most recent data from 2016 to 2019 to identify changes in AMR and risk groups. Results showed that ceftriaxone resistance remained low in 2022, while cefixime resistance decreased. Azithromycin and ciprofloxacin resistance increased, and fema…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage